Insiders · LJPC

LJPC insider transactions

La Jolla Pharmaceutical Company (LJPC) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for LJPC

• 1383d
  SEC Form 4 filed by Rosen Robert

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1383d
  SEC Form 4: Ramsay David A returned $623,000 worth of shares to the company (100,000 units at $6.23), closing all direct ownership in the company

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1383d
  SEC Form 4 filed by Tang Kevin C

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1383d
  SEC Form 4: Edwards Larry G. returned $74,567 worth of shares to the company (11,969 units at $6.23), closing all direct ownership in the company

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1383d
  SEC Form 4 filed by Hearne Michael S

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1383d
  SEC Form 4: Johnson Laura L. returned $3,115 worth of shares to the company (500 units at $6.23), closing all direct ownership in the company

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1383d
  SEC Form 4: Johnson Craig A returned $74,760 worth of shares to the company (12,000 units at $6.23), closing all direct ownership in the company

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1383d
  SEC Form 4: Hearne Michael S returned $63,459 worth of shares to the company (10,186 units at $6.23), closing all direct ownership in the company

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1383d
  SEC Form 4 filed by Tang Kevin C

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1426d
  SEC Form 4: Johnson Craig A exercised 12,000 shares at a strike of $3.93

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1433d
  SEC Form 4: Hearne Michael S was granted 236 shares, increasing direct ownership by 2% to 10,186 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1451d
  SEC Form 4: Hearne Michael S was granted 236 shares, increasing direct ownership by 2% to 9,950 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1466d
  SEC Form 4: Hearne Michael S was granted 189 shares, increasing direct ownership by 2% to 9,714 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1482d
  SEC Form 4: Hearne Michael S was granted 188 shares, increasing direct ownership by 2% to 9,525 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1496d
  SEC Form 4: Hearne Michael S was granted 185 shares, increasing direct ownership by 2% to 9,337 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1511d
  SEC Form 4: Edwards Larry G. was granted 296 shares, increasing direct ownership by 3% to 11,969 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1511d
  SEC Form 4: Hearne Michael S was granted 173 shares, increasing direct ownership by 2% to 9,152 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1525d
  SEC Form 4: Edwards Larry G. was granted 334 shares, increasing direct ownership by 3% to 11,673 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1525d
  SEC Form 4: Hearne Michael S was granted 177 shares, increasing direct ownership by 2% to 8,979 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1543d
  SEC Form 4: Edwards Larry G. was granted 361 shares, increasing direct ownership by 3% to 11,339 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1543d
  SEC Form 4: Hearne Michael S was granted 190 shares, increasing direct ownership by 2% to 8,802 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1558d
  SEC Form 4: Edwards Larry G. was granted 350 shares, increasing direct ownership by 3% to 10,978 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1558d
  SEC Form 4: Hearne Michael S was granted 185 shares, increasing direct ownership by 2% to 8,612 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1571d
  SEC Form 4: Edwards Larry G. was granted 320 shares, increasing direct ownership by 3% to 10,628 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1571d
  SEC Form 4: Hearne Michael S was granted 169 shares, increasing direct ownership by 2% to 8,427 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1586d
  SEC Form 4: Edwards Larry G. was granted 4,170 shares, increasing direct ownership by 68% to 10,308 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1586d
  SEC Form 4: Hearne Michael S was granted 1,675 shares, increasing direct ownership by 25% to 8,258 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1600d
  SEC Form 4: Edwards Larry G. was granted 273 shares, increasing direct ownership by 5% to 6,138 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1600d
  SEC Form 4: Hearne Michael S was granted 148 shares, increasing direct ownership by 2% to 6,583 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1605d
  SEC Form 4 filed by Johnson Craig A

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1605d
  SEC Form 4 filed by Ramsay David A

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1605d
  SEC Form 4 filed by Rosen Robert

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1605d
  SEC Form 4 filed by Johnson Laura L.

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1605d
  SEC Form 4 filed by Edwards Larry G.

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1605d
  SEC Form 4 filed by Hearne Michael S

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1605d
  SEC Form 4 filed by Tang Kevin C

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1615d
  SEC Form 4: Edwards Larry G. was granted 233 shares, increasing direct ownership by 4% to 5,865 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1615d
  SEC Form 4: Hearne Michael S was granted 157 shares, increasing direct ownership by 3% to 6,435 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1633d
  SEC Form 4: Edwards Larry G. was granted 320 shares, increasing direct ownership by 6% to 5,632 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1633d
  SEC Form 4: Hearne Michael S was granted 173 shares, increasing direct ownership by 3% to 6,278 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1644d
  SEC Form 4: Ramsay David A bought $91,990 worth of shares (24,500 units at $3.75), increasing direct ownership by 32% to 100,000 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1648d
  SEC Form 4: Edwards Larry G. was granted 346 shares, increasing direct ownership by 7% to 5,312 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1648d
  SEC Form 4: Hearne Michael S was granted 186 shares, increasing direct ownership by 3% to 6,105 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1649d
  SEC Form 4: Tang Kevin C sold $1,734,150 worth of shares (441,290 units at $3.93)

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1661d
  SEC Form 4: Ramsay David A bought $31,725 worth of shares (7,500 units at $4.23), increasing direct ownership by 11% to 75,500 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1663d
  SEC Form 4: Edwards Larry G. was granted 336 shares, increasing direct ownership by 7% to 4,966 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1663d
  SEC Form 4: Hearne Michael S was granted 181 shares, increasing direct ownership by 3% to 5,919 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1678d
  SEC Form 4: Edwards Larry G. was granted 335 shares, increasing direct ownership by 8% to 4,630 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1678d
  SEC Form 4: Hearne Michael S was granted 181 shares, increasing direct ownership by 3% to 5,738 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1692d
  SEC Form 4: Edwards Larry G. was granted 341 shares, increasing direct ownership by 9% to 4,295 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1692d
  SEC Form 4: Hearne Michael S was granted 183 shares, increasing direct ownership by 3% to 5,557 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1707d
  SEC Form 4: Edwards Larry G. was granted 338 shares, increasing direct ownership by 9% to 3,954 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1707d
  SEC Form 4: Hearne Michael S was granted 182 shares, increasing direct ownership by 4% to 5,374 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1724d
  SEC Form 4: Hearne Michael S was granted 546 units of Common Stock, increasing direct ownership by 12% to 5,192 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1724d
  SEC Form 4: Edwards Larry G. was granted 338 units of Common Stock, increasing direct ownership by 10% to 3,616 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1739d
  SEC Form 4: Edwards Larry G. was granted 320 units of Common Stock, increasing direct ownership by 11% to 3,278 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1755d
  SEC Form 4: Edwards Larry G. was granted 338 units of Common Stock, increasing direct ownership by 13% to 2,958 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1769d
  SEC Form 4: Edwards Larry G. was granted 374 units of Common Stock, increasing direct ownership by 17% to 2,620 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1769d
  SEC Form 4: Hearne Michael S was granted 201 units of Common Stock, increasing direct ownership by 5% to 4,646 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)
• 1784d
  SEC Form 4: Hearne Michael S was granted 193 units of Common Stock, increasing direct ownership by 5% to 4,445 units

  4 - LA JOLLA PHARMACEUTICAL CO (0000920465) (Issuer)